The anti-inflammatory pharmacologic profile of CGP 28237 (5-methylsulfonylamino-6-phenoxy-1-indanone)

@article{Bttcher2005TheAP,
  title={The anti-inflammatory pharmacologic profile of CGP 28237 (5-methylsulfonylamino-6-phenoxy-1-indanone)},
  author={I. B{\"o}ttcher and B. Jagher and C. Rordorf-Adam and M. Gr{\"u}ninger},
  journal={Agents and Actions},
  year={2005},
  volume={21},
  pages={235-237}
}
  • I. Böttcher, B. Jagher, +1 author M. Grüninger
  • Published 2005
  • Medicine
  • Agents and Actions
    • View on Springer
    ncbi.nlm.nih.gov

    Tables and Topics from this paper

    Tables

    Explore Further: Topics Discussed in This Paper

    References

    SHOWING 1-9 OF 9 REFERENCES
    The usability of the MRL/1 mouse strain in detection of anti-rheumatic drugs
    • 6
    A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats.
    • 31
    CGP 28237 (ZK 34228), a novel nonsteroidal anti-inflammatory agent without gastro-intestinal uleerogenicity in rats
    • Abstract A 220, 2nd World Conference on Inflammation, Binscience Ediprint,
    • 1987
    Quantitation of serum amyloid P component by an enzyme-linked immunoassay.
    • 16
    Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice.
    • 17
    Effects of oral aspirin and oxaprozin on the development of lupus-like disease in MRL/1 mice.
    • 5
    Correlation between the rise in acute phase proteins and histological evidence of ulceration in the rat following indomethacin treatment [proceedings].
    • 4
    Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
    • 1,484
    • PDF
    [Erythrocyte sedimentation rate].
    • 10